 |
|
Clinical and Economic Assessment of the Omeprazole Test in Patients With Symptoms Suggestive of Gastroesophageal Reflux Disease
Ronnie Fass, MD;
Joshua J. Ofman, MD, MSHS;
Ian M. Gralnek, MD, MSHS;
Cynthia Johnson, MA;
Elizabeth Camargo;
Richard E. Sampliner, MD;
M. Brian Fennerty, MD
Arch Intern Med. 1999;159:2161-2168.
Objective To evaluate the diagnostic accuracy of a trial of a high-dose proton pump inhibitor (the omeprazole test) in detecting gastroesophageal reflux disease (GERD) in patients with heartburn symptoms.
Design A randomized, double-blind, placebo-controlled, crossover trial.
Patients and Setting Forty-three consecutive patients with symptoms suggestive of GERD were enrolled at a Veterans Affairs medical center.
Main Outcome Measures Symptom response to the omeprazole test vs placebo in GERD-positive and GERD-negative patients; sensitivity, specificity, and positive and negative predictive values of the omeprazole test; and cost per correct diagnosis achieved with the omeprazole test compared with traditional diagnostic strategies.
Results Of 42 patients (98%) who completed the study, 35 (83%) were classified as GERD positive and 7 (17%) as GERD negative. Twenty-eight GERD-positive and 3 GERD-negative patients responded to the omeprazole test, providing a sensitivity of 80.0% (95% confidence interval, 66.7%-93.3%) and a specificity of 57.1% (95% confidence interval, 20.5%-93.8%). Economic analysis revealed that the omeprazole test saves $348 per average patient evaluated, and results in a 64% reduction in the number of upper endoscopies performed and a 53% reduction in the use of pH testing.
Conclusions The omeprazole test is sensitive and fairly specific for diagnosing GERD in patients with typical GERD symptoms. This strategy could result in significant cost savings and decreased use of invasive diagnostic tests.
From the Section of Gastroenterology, Department of Medicine, Tucson Veterans Affairs Medical Center and Arizona Health Sciences Center (Drs Fass and Sampliner and Mss Johnson and Camargo); Division of Gastroenterology and Health Services Research, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Ofman); Division of Digestive Diseases, Department of Medicine, University of California Los Angeles Center for the Health Sciences (Dr Gralnek); and Division of Gastroenterology, Department of Medicine, Oregon Health Sciences University, Portland (Dr Fennerty).
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(18):2229-2230.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
Dent et al.
Gut 2004;53:iv1-iv24.
ABSTRACT
| FULL TEXT
Assessment of reflux symptom severity: methodological options and their attributes
Bytzer
Gut 2004;53:iv28-iv34.
ABSTRACT
| FULL TEXT
Short-Term Treatment with Proton-Pump Inhibitors as a Test for Gastroesophageal Reflux Disease: A Meta-Analysis of Diagnostic Test Characteristics
Numans et al.
ANN INTERN MED 2004;140:518-527.
ABSTRACT
| FULL TEXT
Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment
Manes et al.
BMJ 2003;326:1118.
ABSTRACT
| FULL TEXT
Functional heartburn: the stimulus, the pain, and the brain
Fass and Tougas
Gut 2002;51:885-892.
ABSTRACT
| FULL TEXT
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Clinical Applications
Shaheen and Ransohoff
JAMA 2002;287:1982-1986.
ABSTRACT
| FULL TEXT
Prevalence of Upper Respiratory Symptoms in Patients with Symptomatic Gastroesophageal Reflux Disease
THEODOROPOULOS et al.
Am. J. Respir. Crit. Care Med. 2001;164:72-76.
ABSTRACT
| FULL TEXT
|
